Moderna's billionaire CEO draws criticism for earning nearly $400 million in stock options last year, and then getting a raise on top of it
Moderna CEO Stéphane Bancel joined the firm in 2011 before its rise to the top of the pharmaceutical industry. Chip Somodevilla/Getty French businessman Stéphane Bancel made $393 million in stock options in 2022, according to securities filings...